15/10/02说明:此前论坛服务器频繁出错,现已更换服务器。今后论坛继续数据库备份,不备份上传附件。

肝胆相照论坛

 

 

肝胆相照论坛 论坛 学术讨论& HBV English IPO发行:Aligos Therapeutics准备在美国进行1.5亿美元 ...
查看: 403|回复: 0
go

IPO发行:Aligos Therapeutics准备在美国进行1.5亿美元的IPO [复制链接]

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30437 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

1
发表于 2020-10-13 16:45 |只看该作者 |倒序浏览 |打印
IPO Launch: Aligos Therapeutics Readies $150 Million U.S. IPO

IPOStreet

16 hours ago

Aligos Therapeutics (ALGS) intends to raise $150 million in an IPO of its common stock, according to an S-1 registration statement.

South San Francisco, California-based Aligos was founded to develop a functional cure for Hepatitis B and other liver and viral diseases.

Management is headed by co-founder and CEO Mr. Lawrence Blatt, Ph.D., who was previously Global Head of Infectious Diseases and Vaccines at Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson (JNJ).
IPO发行:Aligos Therapeutics准备在美国进行1.5亿美元的IPO

知识产权局

16小时前

根据S-1注册声明,Aligos Therapeutics(ALGS)打算通过首次公开募股筹集1.5亿美元。

成立于加利福尼亚州南旧金山的Aligos成立是为了开发针对乙型肝炎以及其他肝脏和病毒性疾病的功能性疗法。

管理层由联合创始人兼首席执行官Lawrence Blatt博士领导,他曾是强生(JNJ)子公司Janssen Pharmaceutical Companies的传染病和疫苗全球主管。

https://www.thestreet.com/ipo/news/aligos-therapeutics-ipo-launch
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册

肝胆相照论坛

GMT+8, 2024-11-16 12:07 , Processed in 0.012732 second(s), 11 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.